Concentração sérica de vitamina D, carga viral e sintomas de COVID-19 em pacientes ambulatoriais

Autores

  • Vanessa Brito Lira de Carvalho Federal University of Piauí, Teresina (PI), Brazil https://orcid.org/0000-0002-9255-4961
  • Margarete Almeida Freitas de Azevedo Federal University of Piauí, Teresina (PI), Brazil https://orcid.org/0000-0003-0261-1481
  • Maisa Guimarães Silva Primo Federal University of Piauí, Teresina (PI), Brazil
  • Liriane Andressa Alves da Silva Federal University of Piauí, Teresina (PI), Brazil https://orcid.org/0000-0002-0697-8128
  • José Couras da Silva Filho Federal University of Piauí, University Hospital, Teresina (PI), Brazil
  • Adelino Soares Lima Neto Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil https://orcid.org/0000-0002-9370-0203
  • José Miguel Luz Parente Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil https://orcid.org/0000-0003-4563-2784
  • Maria do Carmo de Carvalho Martins Federal University of Piauí, Department of Biophysics and Physiology, Teresina (PI), Brazil https://orcid.org/0000-0002-9107-2485

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2026.230013

Palavras-chave:

COVID-19, Carga viral, Vitamina D

Resumo

Objetivo: Avaliar a relação entre a concentração sérica de vitamina D, a carga viral e os sintomas da COVID-19 em pacientes ambulatoriais. Métodos: Estudo transversal com 105 adultos atendidos em regime ambulatorial em Teresina, Brasil. As concentrações séricas de 25-hidroxivitamina D foram
mensuradas por eletroquimioluminescência, e a carga viral foi estimada por meio dos valores de cycle threshold (Ct) obtidos por RT-qPCR. Dados sociodemográficos e clínicos foram coletados
por meio de entrevistas estruturadas. As associações foram analisadas com os testes de Wilcoxon e Kruskal-Wallis. Resultados: As medianas da concentração sérica de vitamina D variaram de 27,0 a 33,4 ng/mL Não houve diferenças significativas nos níveis de vitamina D segundo idade,  sexo, renda, escolaridade ou presença de comorbidades. No entanto, indivíduos sem companheiro apresentaram níveis mais baixos de vitamina D (30,2 ng/mL) em comparação aos que tinham companheiro (33,48 ng/mL, p = 0,020). PParticipantes com tosse (p = 0,014) e com dores no corpo (p = 0,029) apresentaram concentrações mais elevadas de vitamina D. Não foi observada associação

Downloads

Os dados de download ainda não estão disponíveis.

Biografia do Autor

  • Vanessa Brito Lira de Carvalho, Federal University of Piauí, Teresina (PI), Brazil

    PhD student 

  • Margarete Almeida Freitas de Azevedo, Federal University of Piauí, Teresina (PI), Brazil

    PhD student 

  • Maisa Guimarães Silva Primo, Federal University of Piauí, Teresina (PI), Brazil

    PhD student 

  • Liriane Andressa Alves da Silva, Federal University of Piauí, Teresina (PI), Brazil

    MSc 

  • José Couras da Silva Filho, Federal University of Piauí, University Hospital, Teresina (PI), Brazil

    PhD 

  • Adelino Soares Lima Neto, Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil

    PhD 

  • José Miguel Luz Parente, Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil

    PhD 

  • Maria do Carmo de Carvalho Martins, Federal University of Piauí, Department of Biophysics and Physiology, Teresina (PI), Brazil

    Post-Doctorate 

Referências

1. Lu CC, Chen MY, Chang YL. Potential therapeutic agents against COVID-19: What we know so far. J Chin Med Assoc. 2020;83(6):534-536. Available at: https:// doi: 10.1097/JCMA.0000000000000318

2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of hospitalized adult patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. Available at: https:// doi: 10.1016/S0140-6736(20)30566-3

3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of pneumonia caused by the new coronavirus. N Engl J Med 2020;382(13):1199-1207. Available at: https://doi: 10.1056/NEJMoa2001316

4. Wang W, Tang J, Wei F. Updated understanding of the 2019 novel coronavirus (2019 - nCoV) outbreak in Wuhan, China. J Med Virol. 2020;92(4):441-447.

Available at: https://doi.org/10.1002/jmv.25689

5. Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479-490. Available at: https://doi.org/10.1002/jmv.25689

6. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML, et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010;5(6):e 11088.

Available at: https://doi.org/10.1371/journal.pone.0011088

7. Pinzon RT, Angela Pradana , AW. Vitamin D deficiency among patients with COVID-19: case series and recent literature review. Trop Med Health. 2020;48(1): 102. Available at : https://doi.org/10.1186/s41182-020-00277-w

8. Charoenngam N, Holick MF. Immunological effects of vitamin D on human health and disease. Nutrients. 2020;12(7):2097. Available at: https://doi.org/10.3390/nu12072097

9. Bilezikian JP, Bikle D, Hewison M, Lazaretti -Castro M, Formenti AM, Gupta A, et al. Mechanisms in endocrinology: Vitamin D and COVID-19. Eur J Endocrinol. 2020; 183(5):R133-R147. Available at: https://doi.org/10.1530/EJE-20-0665

10. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J , et al. Association between vitamin D deficiency and treatment and incidence of COVID-19. medRxiv . 2020. Available at : https://doi: 10.1101/2020.05.08.20095893.

11. Malaguarnera L. Vitamin D3 as a potential adjuvant in the treatment of COVID-19. Nutrients. 2020;12(11):3512. Available at: https://doi.org/10.3390/nu12113512

12. Aranha C, Patel V, Bhor V, Gogoi D. Cycle threshold values in RT-PCR to determine SARS-CoV-2 viral load dynamics: an approach to reduce the isolation period of patients with COVID-19. J Med Virol. 2021;93(12):6794-6797. Available at : https://doi.org/10.1002/jmv.27206

13. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Recommended Daily Intakes of Calcium and Vitamin D. Washington (DC): National Academies Press (USA); 2011.

14. Tsun LY, Tafuni A, Affonso Fonseca FL, da Veiga GL, Macedo Gaiatto AC, de Godoy Moreira E Costa N, et al. Quantification of Vitamin D at Different Levels of Clinical Worsening of COVID-19. Curr Medicamento Metab. 2022;23(14):1124-1129. Available at: https://doi.org/10.2174/1389200224666230109162132

15. Szeto B, Zucker JE, LaSota ED, Rubin MR, Walker MD, Yin MT, et al. Vitamin D status and clinical outcomes of COVID-19 in hospitalized patients. Endocr Res. 2021;46(2):66-73. Available at: https://doi.org/10.1080/07435800.2020.1867162

16. Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240-4270. Available at: https://doi.org/10.3390/nu7064240

17. Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D levels among asymptomatic and critically ill patients with COVID-19 and its correlation with inflammatory markers. Sci Rep. 2020;10(1):20191. Available at : https://doi.org/10.1038/s41598-020-77093-z

18. Rabaan AA, Tirupathi R, Sule AA, Aldali J, Mutair AA, Alhumaid S, et al. Viral dynamics and real-time RT-PCR Ct values correlate with disease severity in COVID-19. Diagnosis. 2021;11(6):1091. Available at: https://doi.org/10.3390/diagnostics11061091

19. Jassil NK, Sharma A, Bikle D, Wang X. Vitamin D-binding protein and 25-hydroxyvitamin D levels: emerging clinical applications. Endocr. Pract. 2017;23(5):605-613. Available at : https://doi.org/10.4158/EP161604.RA

Downloads

Publicado

2026-11-18

Edição

Seção

Artigo Original

Como Citar

1.
Carvalho VBL de, Azevedo MAF de, Primo MGS, Silva LAA da, Silva Filho JC da, Lima Neto AS, et al. Concentração sérica de vitamina D, carga viral e sintomas de COVID-19 em pacientes ambulatoriais. Medicina (Ribeirão Preto) [Internet]. 18º de novembro de 2026 [citado 18º de novembro de 2026];59(1):e-230013. Disponível em: https://revistas.usp.br/rmrp/article/view/230013